Enovix (NASDAQ:ENVX - Get Free Report) is expected to issue its Q4 2025 results before the market opens on Wednesday, February 18th. Analysts expect the company to announce earnings of ($0.17) per share for the quarter. Investors can check the company's upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, February 19, 2026 at 4:00 PM ET.
Enovix Trading Down 3.1%
Shares of Enovix stock opened at $6.28 on Wednesday. Enovix has a 1 year low of $5.27 and a 1 year high of $16.49. The company has a market capitalization of $1.36 billion, a P/E ratio of -7.75 and a beta of 2.13. The company's fifty day moving average is $7.74 and its two-hundred day moving average is $9.42. The company has a debt-to-equity ratio of 1.74, a quick ratio of 9.47 and a current ratio of 9.72.
Analysts Set New Price Targets
Several equities research analysts have recently commented on ENVX shares. Canaccord Genuity Group cut their price target on Enovix from $22.00 to $21.00 and set a "buy" rating for the company in a research note on Thursday, November 6th. Northland Securities set a $16.00 target price on shares of Enovix in a research report on Monday, November 17th. Oppenheimer set a $24.00 price target on shares of Enovix in a report on Thursday, November 6th. JPMorgan Chase & Co. reduced their price objective on shares of Enovix from $12.00 to $10.00 and set a "neutral" rating for the company in a research note on Wednesday, November 12th. Finally, Cantor Fitzgerald lowered their target price on shares of Enovix from $30.00 to $25.00 and set an "overweight" rating on the stock in a research report on Thursday, November 6th. Five analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Enovix presently has an average rating of "Hold" and a consensus target price of $17.50.
View Our Latest Research Report on ENVX
Hedge Funds Weigh In On Enovix
Several institutional investors and hedge funds have recently modified their holdings of ENVX. Parallel Advisors LLC grew its stake in Enovix by 51.9% in the 3rd quarter. Parallel Advisors LLC now owns 3,926 shares of the company's stock worth $39,000 after acquiring an additional 1,342 shares during the period. CIBC Asset Management Inc acquired a new stake in shares of Enovix during the fourth quarter worth $78,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of Enovix in the third quarter valued at $80,000. Mercer Global Advisors Inc. ADV acquired a new position in Enovix in the third quarter valued at $100,000. Finally, Headlands Technologies LLC purchased a new position in Enovix during the second quarter worth about $132,000. Hedge funds and other institutional investors own 50.92% of the company's stock.
Enovix Company Profile
(
Get Free Report)
Enovix Corporation NASDAQ: ENVX develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
